|
Market Data
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. is a global provider of containment and delivery systems for injectable drugs and healthcare products, serving the pharmaceutical industry across multiple continents. The company operates through two primary segments: Proprietary Products and Contract-Manufactured Products. Its Proprietary Products segment focuses on developing and supplying critical components like stoppers, seals, syringes, and advanced drug delivery systems, including innovative solutions like Crystal Zenith. Simultaneously, the Contract-Manufactured Products segment designs and assembles devices for surgical, diagnostic, and drug delivery applications. West Pharmaceutical Services, Inc. distributes its products through a combination of direct sales, distribution networks, and contract agents, solidifying its position as a key partner for pharmaceutical and medical device companies.
WST is currently trading at $266.50, giving West Pharmaceutical Services, Inc. a market cap of 18.90B and a P/E ratio of 38.3. Today's range spans $265.24–$271.29, with shares opening at $268.69 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 86/100 (BUY) with a news sentiment reading of 75/100.
Over the past year WST has traded between $193.05 and $322.34 - the current price is +38.0% off the 52-week low and -17.3% from the high. 25 analysts cover the stock with a Buy consensus and a mean 12-month target of $323.57 (range $265.00–$375.00), implying upside of +21.4%.
What WST has right now - BUY signal, 86/100 technical score, bullish sentiment at 75/100, price $266.50 (in the middle of its 52-week range) - is the profile that shows up in screens looking for Healthcare growth stories with technical confirmation. (P/E: 38.3) At 18.90B in capitalization, the risk/reward of a setup like this is often better than in mega-cap peers where the same signal translates to a smaller percentage move. Range: $193.05–$322.34.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.68 | - | - |
| Q4'25 | $1.67 | $2.04 | +22.1% |
| Q3'25 | $1.71 | $1.96 | +14.6% |
| Q2'25 | $1.54 | $1.84 | +19.7% |
| Q1'25 | $1.26 | $1.45 | +15.3% |
| Q4'24 | $1.73 | $1.82 | +5.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $779M | - | - |
| Q4'25 | $773M | $805M | +4.1% |
| Q3'25 | - | $805M | - |
| Q2'25 | - | $767M | - |
| Q1'25 | - | $698M | - |
| Q4'24 | - | $749M | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).